Insider Transactions in Q2 2021 at Atai Life Sciences N.V. (ATAI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2021
|
Gregory L Weaver Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,666
+50.0%
|
$69,990
$15.0 P/Share
|
|
Jun 22
2021
|
Michael Auerbach |
BUY
Open market or private purchase
|
Indirect |
4,666
+0.08%
|
$69,990
$15.0 P/Share
|
|
Jun 22
2021
|
Christian Angermayer |
BUY
Open market or private purchase
|
Indirect |
700,000
+3.35%
|
$10,500,000
$15.0 P/Share
|
|
Jun 22
2021
|
Florian Brand |
BUY
Open market or private purchase
|
Indirect |
2,333
+50.0%
|
$34,995
$15.0 P/Share
|
|
Jun 22
2021
|
Alexis De Rosnay Director |
BUY
Open market or private purchase
|
Direct |
4,666
+50.0%
|
$69,990
$15.0 P/Share
|
|
Jun 22
2021
|
Srinivas Rao |
BUY
Open market or private purchase
|
Indirect |
3,500
+50.0%
|
$52,500
$15.0 P/Share
|
|
Jun 22
2021
|
Apeiron Investment Group Ltd. |
BUY
Open market or private purchase
|
Indirect |
700,000
+3.35%
|
$10,500,000
$15.0 P/Share
|
|
Jun 22
2021
|
Andrea Heslin Smiley |
BUY
Open market or private purchase
|
Direct |
4,666
+50.0%
|
$69,990
$15.0 P/Share
|
|
Jun 22
2021
|
Amir H Kalali |
BUY
Open market or private purchase
|
Direct |
4,666
+50.0%
|
$69,990
$15.0 P/Share
|